|1||Active, not recruiting||
A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL
A Phase I Extension Trial of Repeated Infusions of ISF35
A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
† Study has passed its completion date and status has not been verified in more than two years.